Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?
Open Access
- 19 August 2008
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (5), 689-694
- https://doi.org/10.1038/sj.bjc.6604557
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-RegulationClinical Cancer Research, 2007
- Phase I Trial of Histone Deacetylase Inhibition by Valproic Acid Followed by the Topoisomerase II Inhibitor Epirubicin in Advanced Solid Tumors: A Clinical and Translational StudyJournal of Clinical Oncology, 2007
- Valproic acid induces apoptosis, p16INK4Aupregulation and sensitization to chemotherapy in human melanoma cellsCancer Biology & Therapy, 2007
- Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylationCancer Biology & Therapy, 2007
- Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cellsBreast Cancer Research and Treatment, 2006
- Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of γ-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non–Small Cell Lung CancerCancer Research, 2006
- Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cellsMolecular Cancer Therapeutics, 2006
- Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid NeoplasmsCancer Research, 2006
- Modulation of cellular radiation responses by histone deacetylase inhibitorsOncogene, 2006
- Sensing of Ionizing Radiation-induced DNA Damage by ATM through Interaction with Histone DeacetylaseJournal of Biological Chemistry, 1999